Related references
Note: Only part of the references are listed.Targeting early stages of cardiotoxicity from anti-PD1 immune checkpoint inhibitor therapy
Lars Michel et al.
EUROPEAN HEART JOURNAL (2022)
Inhibition of IL-17A Protects against Thyroid Immune-Related Adverse Events while Preserving Checkpoint Inhibitor Antitumor Efficacy br
Melissa G. Lechner et al.
JOURNAL OF IMMUNOLOGY (2022)
Towards standardization of echocardiography for the evaluation of left ventricular function in adult rodents: a position paper of the ESC Working Group on Myocardial Function
Serena Zacchigna et al.
CARDIOVASCULAR RESEARCH (2021)
The risk of cardiac events in patients receiving immune checkpoint inhibitors a nationwide Danish study
Maria D'Souza et al.
EUROPEAN HEART JOURNAL (2021)
A Genetic Mouse Model Recapitulates Immune Checkpoint Inhibitors-Associated Myocarditis and Supports a Mechanism-Based Therapeutic Intervention
Spencer C. Wei et al.
CANCER DISCOVERY (2021)
Blocking IL-17A enhances tumor response to anti-PD-1 immunotherapy in microsatellite stable colorectal cancer
Chao Liu et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Interleukin-17 upregulation participates in the pathogenesis of heart failure in mice via NF-κB-dependent suppression of SERCA2a and Cav1.2 expression
Gen-long Xue et al.
ACTA PHARMACOLOGICA SINICA (2021)
Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis
Kamran Ghoreschi et al.
LANCET (2021)
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Enzymes
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Catalytic receptors
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Ion channels
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Introduction and Other Protein Targets
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein-coupled receptors
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Nuclear hormone receptors
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Transporters
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
The risk of cardiac events in patients receiving immune checkpoint inhibitors: a nationwide Danish study
Maria D'Souza et al.
EUROPEAN HEART JOURNAL (2021)
Cardio-Immuno-Oncology
Vlad G. Zaha et al.
CIRCULATION (2020)
Late cardiac adverse events in patients with cancer treated with immune checkpoint inhibitors
Charles Dolladille et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
A practical guide for transparent reporting of research on natural products in the British Journal of Pharmacology: Reproducibility of natural product research
Angelo A. Izzo et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Programmed Cell Death-1: Programmed Cell Death-Ligand 1 Interaction Protects Human Cardiomyocytes Against T-Cell Mediated Inflammation and Apoptosis Response In Vitro
Woan Ting Tay et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
ARRIVE 2.0 and the British Journal of Pharmacology: Updated guidance for 2020
Elliott Lilley et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Association Between Immune Checkpoint Inhibitors With Cardiovascular Events and Atherosclerotic Plaque
Zsofia D. Drobni et al.
CIRCULATION (2020)
The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research
Nathalie Percie du Sert et al.
PLOS BIOLOGY (2020)
Deep immunophenotyping at the single-cell level identifies a combination of anti-IL-17 and checkpoint blockade as an effective treatment in a preclinical model of data-guided personalized immunotherapy
Koji Nagaoka et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Cardiovascular toxicities associated with immune checkpoint inhibitors
Jiun-Ruey Hu et al.
CARDIOVASCULAR RESEARCH (2019)
IL17A Blockade Successfully Treated Psoriasiform Dermatologic Toxicity from Immunotherapy
Daniel Johnson et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Thymic hyperplasia following double immune checkpoint inhibitor therapy in two patients with stage IV melanoma
Justin Mencel et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2019)
Fatal adverse events in two thymoma patients treated with anti-PD-1 immune check point inhibitor and literature review
Thomopoulou Konstantina et al.
LUNG CANCER (2019)
Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype
Daehwan Kim et al.
NATURE BIOTECHNOLOGY (2019)
Immune dysregulation in cancer patients developing immune-related adverse events
Shaheen Khan et al.
BRITISH JOURNAL OF CANCER (2019)
PANTHER version 14: more genomes, a new PANTHER GO-slim and improvements in enrichment analysis tools
Huaiyu Mi et al.
NUCLEIC ACIDS RESEARCH (2019)
CXCR3 regulates CD4+ T cell cardiotropism in pressure overload-induced cardiac dysfunction
Njabulo Ngwenyama et al.
JCI INSIGHT (2019)
Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers
Michael J. Curtis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Myocarditis in Patients Treated With Immune Checkpoint Inhibitors
Syed S. Mahmood et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Immune-Related Adverse Events Associated with Immune Checkpoint Blockade
Michael A. Postow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Takotsubo-Like Syndrome in Cancer Patients Treated With Immune Checkpoint Inhibitors
Stephane Ederhy et al.
JACC-CARDIOVASCULAR IMAGING (2018)
Recent Developments on the Crosstalk Between STAT3 and Inflammation in Heart Function and Disease
Mazen Kurdi et al.
FRONTIERS IN IMMUNOLOGY (2018)
Early dystrophin loss is coincident with the transition of compensated cardiac hypertrophy to heart failure
Fernanda P. Prado et al.
PLOS ONE (2017)
Clinical Features, Management, and Outcomes of Immune Checkpoint Inhibitor-Related Cardiotoxicity
Marion Escudier et al.
CIRCULATION (2017)
Ensembl 2016
Andrew Yates et al.
NUCLEIC ACIDS RESEARCH (2016)
Left Ventricular Dysfunction After Treatment With Ipilimumab for Metastatic Melanoma
Mary E. Roth et al.
AMERICAN JOURNAL OF THERAPEUTICS (2016)
MultiQC: summarize analysis results for multiple tools and samples in a single report
Philip Ewels et al.
BIOINFORMATICS (2016)
Apical takotsubo syndrome in a patient with metastatic breast carcinoma on novel immunotherapy
Robert D. Anderson et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)
Dystrophin-Deficient Cardiomyopathy
Forum Kamdar et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
Douglas B. dbj Johnson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Cardiac STAT3 Deficiency Impairs Contractility and Metabolic Homeostasis in Hypertension
Raffaele Altara et al.
FRONTIERS IN PHARMACOLOGY (2016)
The CXCL10/CXCR3 Axis and Cardiac Inflammation: Implications for Immunotherapy to Treat Infectious and Noninfectious Diseases of the Heart
Raffaele Altara et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2016)
Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapy
Lucie Heinzerling et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2016)
Cardiac myosin-Th17 responses promote heart failure in human myocarditis
Jennifer M. Myers et al.
JCI INSIGHT (2016)
Checkpoint immunotherapy for cancer: superior survival, unaccustomed toxicities
C. Gedye et al.
INTERNAL MEDICINE JOURNAL (2015)
Insights into alternative splicing of sarcomeric genes in the heart
Cornelis J. Weeland et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2015)
Baseline circulating IL-17 predicts toxicity while TGF-β1 and IL-10 are prognostic of relapse in ipilimumab neoadjuvant therapy of melanoma
Ahmad A. Tarhini et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2015)
Apical ballooning and cardiomyopathy in a melanoma patient treated with ipilimumab: a case of takotsubo-like syndrome
Benjamin P. Geisler et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2015)
Cleavage of IκBα by calpain induces myocardial NF-κB activation, TNF-α expression, and cardiac dysfunction in septic mice
Xiaoping Li et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2014)
featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
Yang Liao et al.
BIOINFORMATICS (2014)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
PD-1 Blockade Augments Th1 and Th17 and Suppresses Th2 Responses in Peripheral Blood From Patients With Prostate and Advanced Melanoma Cancer
John Dulos et al.
JOURNAL OF IMMUNOTHERAPY (2012)
Interleukin-17A Is Dispensable for Myocarditis but Essential for the Progression to Dilated Cardiomyopathy
G. Christian Baldeviano et al.
CIRCULATION RESEARCH (2010)
CTLA4 blockade increases Th17 cells in patients with metastatic melanoma
Erika von Euw et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2009)
Deficiency of M2 muscarinic acetylcholine receptors increases susceptibility of ventricular function to chronic adrenergic stress
Carly LaCroix et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
A missense mutation in the CHRM2 gene is associated with familial dilated cardiomyopathy
Lin Zhang et al.
CIRCULATION RESEARCH (2008)
Inhibition of glycogen synthase kinase 3β during heart failure is protective
Shinichi Hirotani et al.
CIRCULATION RESEARCH (2007)
Metabolic and signaling alterations in dystrophin-deficient hearts precede overt cardiomyopathy
Maya Khairallah et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2007)
Innate defense mechanism against virus infection within the cardiac myocyte requiring gp130-STAT3 signaling
Toshitaka Yajima et al.
CIRCULATION (2006)
Nitrosative stress and pharmacological modulation of heart failure
P Pacher et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2005)
Innate immune response in Th1- and Th2-dominant mouse strains
H Watanabe et al.
SHOCK (2004)
Mutations in Cypher/ZASP in patients with dilated cardiomyopathy and left ventricular non-compaction
M Vatta et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Decrease in sarcoglycans and dystrophin in failing heart following acute myocardial infarction
H Yoshida et al.
CARDIOVASCULAR RESEARCH (2003)
Argininosuccinate synthetase from the urea cycle to the citrulline-NO cycle
A Husson et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2003)
Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice
H Nishimura et al.
SCIENCE (2001)
Peroxynitrite is a major contributor to cytokine-induced myocardial contractile failure
P Ferdinandy et al.
CIRCULATION RESEARCH (2000)
Share Paper
